[Federal Register Volume 83, Number 146 (Monday, July 30, 2018)]
[Notices]
[Pages 36607-36608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16156]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2014-N-1069; FDA-2017-N-6931; FDA-2011-N-0362; FDA-
2011-N-0279; FDA-2011-N-0672; FDA-2014-N-0913; FDA-2017-N-0493; and
FDA-2011-N-0781]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
[[Page 36608]]
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Blood Establishment Registration and 0910-0052 6/30/2021
Product Listing for Manufacturers of
Human Blood and Blood Products and
Licensed Devices; Form FDA 2830........
Current Good Manufacturing Practices and 0910-0116 6/30/2021
Related Regulations for Blood and Blood
Components; and Requirements for
Donation Testing, Donor Notification,
and ``Lookback''.......................
Current Good Manufacturing Practices for 0910-0139 6/30/2021
Finished Pharmaceuticals and Medical
Gases..................................
Prescription Drug Marketing............. 0910-0435 6/30/2021
Prominent and Conspicuous Mark of 0910-0577 6/30/2021
Manufacturers on Single-Use Devices....
Guidance FDA and Industry Procedures for 0910-0705 6/30/2021
Section 513(g) Requests for Information
under the Federal Food, Drug, and
Cosmetic Act...........................
Utilization of Adequate Provision Among 0910-0853 6/30/2021
Low to Non-Internet Users..............
Record Retention Requirements for the 0910-0428 7/31/2021
Soy Protein/Coronary Heart Disease
Health Claim...........................
------------------------------------------------------------------------
Dated: July 24, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-16156 Filed 7-27-18; 8:45 am]
BILLING CODE 4164-01-P